Thyroid cancer
Effect of Lenvatinib in reducing the size of Thyroid Cancers which are invading surrounding vital structures
Who can joinAdults
Age18–70 years
Kind of studyPhase 2: does it work?
What it testsA medicine
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Last updated on the registry 18 Aug 2025. Please confirm with the hospital that this trial is still taking patients.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
All India Institute of Medical SciencesNew Delhi, DelhiDirections ↗
Registry summary (technical)
Neoadjuvant Chemotherapy using Lenvatinib in locally advanced differentiated Thyroid Carcinoma- A phase II open label study - Nil
Sponsor: Nil
CTRI/2025/03/082914 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 18 Aug 2025 · read by us 5 Nov 2026